Thymoma type A

Thymoma type A, also known as spindle cell thymoma or medullary thymoma, is a rare neoplasm of the thymus gland, an organ located in the anterior mediastinum (the front part of the chest, behind the breastbone) that plays a key role in immune system development. In the World Health Organization (WHO) classification of thymic epithelial tumors, type A thymoma is composed of bland spindle-shaped or oval epithelial cells with few or no immature T-lymphocytes (thymocytes). It is generally considered one of the most indolent and least aggressive subtypes of thymoma, with an excellent prognosis in most cases. Many patients with thymoma type A are asymptomatic at diagnosis, with the tumor discovered incidentally on chest imaging performed for other reasons. When symptoms do occur, they may include chest pain, cough, shortness of breath, or superior vena cava syndrome due to compression of mediastinal structures. A subset of patients may develop paraneoplastic autoimmune conditions, most notably myasthenia gravis, although this association is less common in type A thymoma compared to other thymoma subtypes such as type B. Other paraneoplastic syndromes, including pure red cell aplasia and hypogammaglobulinemia, have been reported but are rare. The primary treatment for thymoma type A is complete surgical resection (thymectomy), which is curative in the majority of cases, particularly when the tumor is encapsulated and detected at an early stage (Masaoka stage I or II). For locally advanced or incompletely resected tumors, adjuvant radiation therapy may be recommended. Chemotherapy is generally reserved for advanced, recurrent, or unresectable disease. Long-term follow-up is important because late recurrences, although uncommon in type A, can occur even years after initial treatment. Overall survival rates for thymoma type A are among the highest of all thymoma subtypes.

Common questions about Thymoma type A